Abstract
Severe lower respiratory illnesses (sLRI) during infancy increase the of asthma. The immunomodulator BronchVaxom® can increase the time to the first sLRI and reduce the cumulative burden of sLRI in at risk infants.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have